Health, Fitness & Food

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Friday’s key moments. Market still oversold When to buy chip Quick mentions: TJX, DIS, ABBV 1. Market still oversold We’re finally saying goodbye to September — but likely not to all the volatility
0 Comments
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. Market gets an oversold bounce Quick Club mentions: AAPL, LLY, EL 1. Market gets an oversold bounce U.S. stocks recovered after falling earlier Wednesday. Treasury yields pulled back from their highs and
0 Comments
A crosswalk signal is seen outside the U.S. Supreme Court building in Washington, U.S., June 27, 2022. Elizabeth Frantz | Reuters The Supreme Court starting Monday will allow members of the public to attend oral argument hearings for the first time since the Covid-19 lockdown of March 2020, the court’s press office confirmed in a
0 Comments
Positive trial results for Biogen ‘s (BIIB) experimental, late-stage Alzheimer’s treatment are also good news for Club holding Eli Lilly (LLY), which is working in its own drug to battle the disease. Biogen shares rocketed higher by more than 30% on Wednesday as Wall Street cheered the results of the Phase 3 study. Japanese pharmaceutical
0 Comments
In this article PFE Follow your favorite stocksCREATE FREE ACCOUNT Jack Wasserman, 6, receives a Pfizer-BioNTech coronavirus disease (COVID-19) booster vaccine in Schwenksville, Pennsylvania, U.S., May 19, 2022.  Hannah Beier | Reuters Pfizer on Monday asked the Food and Drug Administration to authorize its new Covid booster shots that target the omicron BA.5 subvariant for
0 Comments
Texas Attorney General Ken Paxton leaves the U.S. Supreme Court following arguments over a challenge to a Texas law that bans abortion after six weeks in Washington, U.S., November 1, 2021. Evelyn Hockstein | Reuters Texas Attorney General Ken Paxton fled his home to avoid being served a subpoena Monday in a federal lawsuit filed
0 Comments
In this article BIIB Follow your favorite stocksCREATE FREE ACCOUNT A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen will pay $900 million to settle a lawsuit that alleged the company gave doctors kickbacks to encourage them prescribe its drugs, the Justice Department announced on Monday. A former Biogen employee turned whistleblower, Michael
0 Comments
Following CDC approval for vaccination of children aged 6 months to 5 years, 4 year-old Eleanor Kahn sits with her father Alex, as nurse Jillian Mercer administers the Moderna vaccine for the coronavirus disease (COVID-19) at Rady Children’s Hospital in San Diego, California, U.S., June 21, 2022. Mike Blake | Reuters Moderna has asked the
0 Comments
RT: Maria Van Kerkhove, Head a.i. Emerging Diseases and Zoonosis at the World Health Organization (WHO), speaks during a news conference on the situation of the coronavirus at the United Nations in Geneva, Switzerland, January 29, 2020. Denis Balibouse | Reuters The World Health Organization on Thursday warned that it is struggling to identify and
0 Comments
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. We’re letting our stocks run on Fed day Companies with pricing power are winners here Quick mentions: CSCO, NVDA, QCOM, MRVL, CRM 1. We’re letting our stocks run on Fed
0 Comments
We’re buying 25 shares of Danaher (DHR) at roughly $272.79 each. Following Tuesday’s trade, Jim’s Charitable Trust will own 510 shares of Danaher, increasing its weighting in the portfolio to 4.96% from 4.73%. We’re also buying 100 shares of TJX Companies (TJX) at roughly $63.04 each. Following Tuesday’s trade, the Trust will down 950 shares
0 Comments
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. Now is absolutely not the time to buy Quick mentions: F, HUM, META, CRM, AMZN Exclusive looks into 3 Club names 1. Now is absolutely not the time to buy
0 Comments
Jim Cramer, during Thursday’s “Monthly Meeting,” offered Club members tips to build a strong portfolio that can endure the Federal Reserve’s tempestuous battle to tamp down inflation. As the Fed struggles to stop prices from skyrocketing, they’re also worried wage inflation being fueled by the job-hopping nature of the labor market in the rush back
0 Comments